Cheryl L. Walker

880 total citations
25 papers, 683 citations indexed

About

Cheryl L. Walker is a scholar working on Molecular Biology, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, Cheryl L. Walker has authored 25 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Obstetrics and Gynecology and 6 papers in Genetics. Recurrent topics in Cheryl L. Walker's work include Epigenetics and DNA Methylation (6 papers), Renal and related cancers (6 papers) and Uterine Myomas and Treatments (5 papers). Cheryl L. Walker is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Renal and related cancers (6 papers) and Uterine Myomas and Treatments (5 papers). Cheryl L. Walker collaborates with scholars based in United States, Australia and Indonesia. Cheryl L. Walker's co-authors include Angela Alexander, Jeffrey I. Everitt, Jennifer Cook, Barbara J. Davis, Thomas W. Burke, Shengli Cai, Claudio J. Conti, J. Carl Barrett, Frans H. Rutten and Robin Fuchs‐Young and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and FEBS Letters.

In The Last Decade

Cheryl L. Walker

24 papers receiving 672 citations

Peers

Cheryl L. Walker
Shuanfang Li United States
Emily A. Ricke United States
Tiffany A. Katz United States
J. Rajput-Williams United Kingdom
Michael E. Fant United States
Joseph F. Pulliam United States
Shawn Pan United States
Shuanfang Li United States
Cheryl L. Walker
Citations per year, relative to Cheryl L. Walker Cheryl L. Walker (= 1×) peers Shuanfang Li

Countries citing papers authored by Cheryl L. Walker

Since Specialization
Citations

This map shows the geographic impact of Cheryl L. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl L. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl L. Walker more than expected).

Fields of papers citing papers by Cheryl L. Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl L. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl L. Walker. The network helps show where Cheryl L. Walker may publish in the future.

Co-authorship network of co-authors of Cheryl L. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl L. Walker. A scholar is included among the top collaborators of Cheryl L. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl L. Walker. Cheryl L. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoli, Richard I. Han, Manga Motrapu, et al.. (2025). Lysine demethylase 4A is a centrosome‐associated protein required for centrosome integrity and genomic stability. FEBS Journal. 293(2). 396–417.
2.
Walker, Cheryl L. & Warren W. Burggren. (2020). Remodeling the epigenome and (epi)cytoskeleton: a new paradigm for co-regulation by methylation. Journal of Experimental Biology. 223(13). 22 indexed citations
3.
Kim, Jinhee, et al.. (2011). Immunohistochemical Analysis of mTOR Activity in Tissues. Methods in molecular biology. 821. 215–225. 2 indexed citations
4.
Walker, Cheryl L.. (2011). Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood. Birth Defects Research Part A Clinical and Molecular Teratology. 91(8). 666–671. 26 indexed citations
5.
Hassan, Memy H., Dong Zhang, Farid M.A. Hamada, et al.. (2009). Towards Fibroid Gene Therapy: Adenovirus-Mediated Delivery of Herpes Simplex Virus 1 Thymidine Kinase Gene/Ganciclovir Shrinks Uterine Leiomyoma in the Eker Rat Model. Gynecologic and Obstetric Investigation. 68(1). 19–32. 21 indexed citations
6.
Cook, Jennifer, Barbara J. Davis, Shengli Cai, et al.. (2005). Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proceedings of the National Academy of Sciences. 102(24). 8644–8649. 76 indexed citations
7.
Burke, Thomas W. & Cheryl L. Walker. (2003). Arzoxifene as therapy for endometrial cancer. Gynecologic Oncology. 90(2). S40–S46. 27 indexed citations
8.
Hodges-Gallagher, Leslie, et al.. (2001). An in vivo/in vitro Model to Assess Endocrine Disrupting Activity of Xenoestrogens in Uterine Leiomyoma. Annals of the New York Academy of Sciences. 948(1). 100–111. 21 indexed citations
9.
Kleymenova, Elena, Stephanie J. Muga, Susan M. Fischer, & Cheryl L. Walker. (2000). Application of high-performance liquid chromatography-based analysis of DNA fragments to molecular carcinogenesis. Molecular Carcinogenesis. 29(2). 51–58. 5 indexed citations
10.
Gamage, Shantini D., Eric D. Bischoff, Kevin D. Burroughs, et al.. (2000). Efficacy of LGD1069 (Targretin), a Retinoid X Receptor-Selective Ligand, for Treatment of Uterine Leiomyoma. Journal of Pharmacology and Experimental Therapeutics. 295(2). 677–681. 27 indexed citations
11.
Walker, Cheryl L., S. Ansar Ahmed, Tom Brown, et al.. (1999). Species, interindividual, and tissue specificity in endocrine signaling.. Environmental Health Perspectives. 107(suppl 4). 619–624. 16 indexed citations
12.
Tang, Tong, James D. Owen, Jianguo Du, Cheryl L. Walker, & Ann Richmond. (1998). Molecular Cloning and Characterization of a Mouse Gene with Homology to the Duffy-Antigen Receptor for Chemokines. DNA sequence. 9(3). 129–143. 12 indexed citations
13.
Burroughs, Kevin D., Kaoru Kiguchi, S R Howe, et al.. (1997). Regulation of Apoptosis in Uterine Leiomyomata1. Endocrinology. 138(7). 3056–3064. 30 indexed citations
14.
Everitt, Jeffrey I., Thomas L. Goldsworthy, Douglas C. Wolf, & Cheryl L. Walker. (1995). Hereditary renal cell carcinoma in the Eker rat: a unique animal model for the study of cancer susceptibility. Toxicology Letters. 82-83. 621–625. 26 indexed citations
15.
Rutten, A.A.J.J.L., et al.. (1995). Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.. PubMed. 55(16). 3634–9. 11 indexed citations
16.
Bermudez, Edilberto, Zhuchu Chen, Elizabeth A. Gross, et al.. (1994). Characterization of cell lines derived from formaldehyde‐induced nasal tumors in rats. Molecular Carcinogenesis. 9(4). 193–199. 13 indexed citations
17.
Everitt, Jeffrey I., et al.. (1994). Increased susceptibility to in vitro transformation of cells carrying the Eker tumor susceptibility mutation. Carcinogenesis. 15(10). 2183–2187. 7 indexed citations
18.
Walker, Cheryl L., et al.. (1994). Wilms' tumor suppressor gene expression in rat and human mesothelioma.. PubMed. 54(12). 3101–6. 70 indexed citations
19.
Recio, Leslie, et al.. (1991). Analysis of ras DNA sequences in rat renal cell carcinoma. Molecular Carcinogenesis. 4(5). 350–353. 11 indexed citations
20.
Ferriola, Patrice C., Cheryl L. Walker, Alice Robertson, et al.. (1989). Altered Growth Factor Dependence and Transforming Growth Factor Gene Expression in Transformed Rat Tracheal Epithelial Cells. Molecular Carcinogenesis. 2(6). 336–344. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026